Why Children Should Not Receive the COVID Shot

Story at-a-glance (Dr. Mercola)

  • While Pfizer claims its vaccine is 95% effective, this is the relative risk reduction. The absolute risk reduction — which is far more relevant for public health measures — is actually less than 1%
  • While benefits from COVID “vaccination” in children between the ages of 12 and 15 are rare and short-lived, side effects are common and long-term effects are completely unknown
  • In the 12-to-15 age group, 75.5% experienced headache, along with a long list of other transient side effects. Serious systemic adverse events occurred in 2.4% of the trial subjects receiving Pfizer’s mRNA shot
  • While Pfizer boasted a 100% efficacy rate in 12- to 15-year-olds, this conclusion is a statistical trick. Fewer than 2% of fully vaccinated children avoided COVID-19; 98% of them would not have gotten COVID anyway. So, the benefit is small
  • Even if vaccinating children were found to reduce infection among adults, it would be unethical and against regulations to do so, because the FDA can only authorize the use of a medical product in a given population if the benefit outweighs the risk in that same population, and in children the benefits do not outweigh the risks

https://articles.mercola.com/sites/articles/archive/2021/06/29/children-covid-vaccine.aspx?ui=d8e0407e3d3a1144731fdfc5f11a5177b2eea95a2d99ab4795e6dd1229d9e508&sd=20201221&cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20210629&mid=DM922859&rid=1195905663

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

%d bloggers like this: